2015
DOI: 10.1159/000373968
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of Bim in Photofrin-Mediated Photodynamically Induced Apoptosis

Abstract: Background/Aims: Photodynamic therapy (PDT) is a promising noninvasive technique, which has been successfully applied to the treatment of human cancers. Studies have shown that the Bcl-2 family proteins play important roles in PDT-induced apoptosis. However, whether Bcl-2-interacting mediator of cell death (Bim) is involved in photodynamic treatment remains unknown. In this study, we attempt to determine the effect of Bim on Photofrin photodynamic treatment (PPT)-induced apoptosis in human lung adenocarcinoma … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 35 publications
0
10
0
Order By: Relevance
“…We further identified BIM as the target of miR-24 in OS. BIM belongs to the BH3-only subfamily of Bcl-2 family proteins 28 . Studies have demonstrated that BIM plays a pro-apoptotic role by triggering Bak and Bax, which are additional apoptosis stimuli 29 30 .…”
Section: Discussionmentioning
confidence: 99%
“…We further identified BIM as the target of miR-24 in OS. BIM belongs to the BH3-only subfamily of Bcl-2 family proteins 28 . Studies have demonstrated that BIM plays a pro-apoptotic role by triggering Bak and Bax, which are additional apoptosis stimuli 29 30 .…”
Section: Discussionmentioning
confidence: 99%
“…Western blotting assay was performed as described previously [13]. In brief, the cells were harvested and lysed in RIPA buffer (Cell Signaling, Danvers, USA).…”
Section: Methodsmentioning
confidence: 99%
“…They exhibit remarkable photophysical properties, including high stability, water-solubility, high phototoxicity, and low dark toxicity 8 9 10 . Porfimer sodium (Photofrin II) was the first photosensitizer approved by the US Food and Drug Agency and has already been applied clinically to treat various cancers and non-cancer diseases 11 12 13 14 . However, patients treated with Photofrin II suffer from a skin photosensitivity, requiring protection from sunlight or bright lights exposure for up to 3 months 15 .…”
mentioning
confidence: 99%